🔎 Trials Near Me

Home › Liver Diseases › Colorado

Liver Diseases clinical trials in Colorado

7 studies for Liver Diseases are looking for participants at sites in Colorado.

Cities in Colorado

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

  • 89bio Clinical Study Site, Littleton
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 3, 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

  • 89bio Clinical Study Site, Littleton
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 3, 2026 · NCT06318169

Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)

  • Children's Hospital of Colorado, Anshutz Medical Campus, Aurora
RecruitingObservational study
7 Months – 15 Months · All sexes · Updated Aug 31, 2026 · NCT06805695

An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC Deficiency

  • Children's Hospital of Colorado, Anshutz Medical Campus, Aurora
RecruitingPhase 3
24 Hours – 7 Months · Men · Updated Aug 12, 2026 · NCT06255782

Primary Sclerosing Cholangitis in Children

  • Children's Hospital Colorado, Aurora
RecruitingObservational study
Ages 2 to 25 · All sexes · Updated Jul 14, 2026 · NCT04181138

Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs

  • University of Colorado, Aurora
RecruitingObservational study
Ages 18 to 80 · All sexes · Updated Oct 20, 2025 · NCT04613921

Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)

  • Section of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics and the Digestive Health Institute, Children's Hospital of C, Aurora
RecruitingObservational study
All ages · All sexes · Updated May 25, 2025 · NCT06193928

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.